Search Results for: "program in cellular and molecular medicine"
A new tool could exponentially expand our understanding of bacteria
How do bacteria — harmless ones living in our bodies, or those that cause disease — organize their activities? A …Read More
Bringing order to disorder: Jhullian Alston, PhD
Proteins typically fold into orderly, predictable three-dimensional structures that dictate how they will interact with other molecules. Jhulian Alston, PhD, …Read More
A new anti-cancer strategy: Overriding tumor edits
Cancers are clever and often find ways to dodge people’s immune systems, making them hard to eradicate. Immunotherapies such as …Read More
Building better antibodies, curbing autoimmunity: New insights on B cells
When we’re vaccinated or exposed to an infection, our B cells spring into action, churning out antibodies that are increasingly …Read More
A journey through the intestine during colitis, cell by cell
Inflammatory bowel disease (IBD), causing devastating abdominal pain, persistent diarrhea, and rectal bleeding, is hard to control with current treatments. …Read More
Exposing a tumor’s antigens to enhance immunotherapy
Successful immunotherapy for cancer involves activating a person’s own T cells to attack the tumor. But some tumors have a …Read More
New leads for spinal cord injury: Mapping spinal-projecting neurons in the brain
Only a fraction of people who sustain a spinal cord injury fully regain their motor function. While rehabilitation can help, …Read More
Nanobodies from alpacas could steer immune attacks on influenza
While conventional flu vaccines are designed to anticipate the influenza strains projected to dominate in the next flu season, they’re …Read More
A promising target for ALS and other neurodegenerative disorders: Curbing inflammation
When cells recognize a danger, such as an infection, they activate the innate immune system. Sentinel molecules sound an alarm, …Read More
Powerful new antibody neutralizes all known coronavirus variants
As the COVID-19 pandemic wears on, newer variants of the SARS-CoV-2 coronavirus have been evolving ways to evade the antibodies …Read More